StockData
Alnylam Pharmaceuticals, Inc. logo

Alnylam Pharmaceuticals, Inc.

ALNYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 10/3048% below fair value
$143.82−4.00 (-2.71%)

Close on Nov 20, 2026Market cap $19.26BP/E 7.5Yield –

Alnylam Pharmaceuticals Net Cash Provided by Operating Activities

Net Cash Provided by (Used in) Operating Activities ($M)

Alnylam Pharmaceuticals Net Cash Provided by Operating Activities: $341M in Q3 2026, up 14.9% from a year earlier.

Latest, Q3 2026
341
Period ended Sep 30, 2026
Change on a year earlier
+14.9%
297 in Q3 2025
History
43 quarters
Since Q1 2016
Sources
39
Documents cited below

Where the Q3 2026 figure comes from

Calculated from reported figures: quarter = year-to-date − previous year-to-date (cash flow statement)

Source: Alnylam Form 10-Q (filed 2026-10-29) ↗

Reported in Form 10-Q & Form 10-K Consolidated Statements of Cash Flows.

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNet Cash Provided by (Used in) Operating Activities ($M)Year on yearSource
Q3 2026Sep 30, 2026341+14.9%Alnylam Form 10-Q (filed 2026-10-29) ↗
Q2 2026Jun 30, 2026327+151.7%Alnylam Form 10-Q (filed 2026-07-30) ↗
Q1 2026Mar 31, 202670.5-158.6%Alnylam Form 10-Q (filed 2026-04-30) ↗
Q4 2025Dec 31, 2025218-329.9%Alnylam Form 10-Q (filed 2026-10-29) ↗
Q3 2025Sep 30, 2025297+579.4%Alnylam Form 10-Q (filed 2026-10-29) ↗
Q2 2025Jun 30, 2025130+4.5%Alnylam Form 10-Q (filed 2026-07-30) ↗
Q1 2025Mar 31, 2025-120+47.6%Alnylam Form 10-Q (filed 2026-04-30) ↗
Q4 2024Dec 31, 2024-94.7+217.8%Alnylam Form 10-K (filed 2025-02-13) ↗
Q3 2024Sep 30, 202443.7-87.8%Alnylam Form 10-Q (filed 2024-10-31) ↗
Q2 2024Jun 30, 2024124-310.5%Alnylam Form 10-Q (filed 2024-08-01) ↗
Q1 2024Mar 31, 2024-81.5-51.1%Alnylam Form 10-Q (filed 2024-05-02) ↗
Q4 2023Dec 31, 2023-29.8-77.4%Alnylam Form 10-K (filed 2024-02-15) ↗
Q3 2023Sep 30, 2023359-411.7%Alnylam Form 10-Q (filed 2023-11-02) ↗
Q2 2023Jun 30, 2023-59-52.0%Alnylam Form 10-Q (filed 2023-08-03) ↗
Q1 2023Mar 31, 2023-167-2.7%Alnylam Form 10-Q (filed 2023-05-04) ↗
Q4 2022Dec 31, 2022-132-12.1%Alnylam Form 10-K (filed 2023-02-23) ↗

Breakdown

What makes up net Cash Provided by Operating Activities

Cite this data

StockData. (2026). Alnylam Pharmaceuticals Net Cash Provided by Operating Activities ($M), quarterly Q1 2016–Q3 2026 [Data set]. Compiled from Alnylam Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/alny/kpis/db-operating-cf

See every metric in the Alnylam Pharmaceuticals KPI table. Data updated Nov 10, 2026.

See a number that looks wrong?